Navigation Links
Ann E. Berman To Join the Board of Directors of Cantel Medical Corp.
Date:3/22/2011

LITTLE FALLS, N.J., March 22, 2011 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMN) today announced the appointment of Ann E. Berman to serve as an independent member of Cantel's Board of Directors.

Ms. Berman is the former Chief Financial Officer (2002-2006) of Harvard University. As CFO of Harvard, Ms. Berman was responsible for an operating budget of more than $2.8 billion, and net assets in excess of $30 billion. As CFO, Ms. Berman brought a focus on the quality of financial management and "best practice" standards to Harvard. She was responsible for establishing and maintaining an adequate and effective internal control structure within the University, and worked closely with the University's audit committee to minimize risk. Her areas of responsibility included financial strategy and policy; Treasury functions, including debt issuance and cash management; risk management and audit services; oversight and administration of government sponsored research; financial reporting; financial operations; and budget and financial planning.

In her role on the Harvard Management Company Board, Ms. Berman participated in the work of the Finance/Audit Committee and the Valuation Committee. She was responsible for a governance review of the Management Company and its Board.

Ms. Berman serves on the Board of Directors and Audit Committee of Loews Corporation, a diversified holding company, and as a board member and the Chair of the Audit Committee of Eaton Vance Corporation, an investment manager of over $150 billion in investment funds and separate accounts.

Before moving into higher education administration, Ms. Berman was a partner at Richard A. Eisner & Co., a New York-based regional accounting firm, where she specialized in tax and consulting work for a wide range of corporate and individual clients. She began her career with Price Waterhouse & Co., where she worked in both audit and taxation. Ms. Berman holds a B.A. from Cornell University where she was elected to Phi Beta Kappa, and an MBA from the Wharton School of the University of Pennsylvania. She is also a certified public accountant.

Charles M. Diker, Cantel's Chairman, commented, "We are delighted to have somebody as accomplished as Ann join our board, and we look forward to benefitting from her broad experience and expertise in financial management, reporting, and corporate governance."

About Cantel Medical Corp.

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing systems for endoscopy and renal dialysis, disposable infection control products primarily for the dental industry, dialysate concentrates and other dialysis supplies, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
2. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
3. American Board of Internal Medicine President Named to Alzheimers Study Group
4. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
5. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
6. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
7. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
8. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
9. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
10. Silence Therapeutics Announces Board Changes
11. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 2016 Global Paclitaxel Market 2016 ... 12 companies and the Paclitaxel analysis in this study ... industry and its players. This is the ... details the current state of the industry while providing ... applications and industry chain structure. The Paclitaxel market analysis ...
(Date:5/23/2016)... May 23, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 ... Other), by Application (Drug Discovery and Development, Proteomics, ... (Pharmaceuticals, Life Science and Biotechnology, Academic and Research ... Research, the global mass spectrometry market ...
(Date:5/23/2016)... , May 23, 2016 ... for detection of multiple diseases; ,Technology to be presented ... Yissum Research Development Company of the Hebrew ... into a research agreement with Aurum Ventures MKI, the technology ... development of a new diagnostic approach for early detection ...
Breaking Medicine Technology:
(Date:5/24/2016)... , ... May 24, 2016 , ... How to Write ... Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major ... human error will ever be totally eliminated, many human performance problems can be prevented. ...
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health (LLUH) has officially broken ... Children’s Hospital. Over 3,000 people looked on as the shovels hit the dirt at ... slidehsow. , During the program, Richard H. Hart, MD, DrPH, president, LLUH, recapped ...
(Date:5/24/2016)... ... May 24, 2016 , ... Eggsurance, ... the official relaunch of its community and education hub for women considering fertility ... is to create a safe and welcoming place for women to find cycle ...
(Date:5/24/2016)... ... May 24, 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, powered ... Young Living Essential Oils, taught by Patti Dolan, RYT, a Young Living Gold ... Flow is 6:30pm - 7:15pm followed by a small intro to the Oils that ...
(Date:5/24/2016)... ... May 24, 2016 , ... In light of recent heavy flooding in Houston, ... contaminated well water throughout the Houston area. , Heavy floodwaters have led to destroyed ... to contaminants. Residents may not even be aware of the contamination of their water ...
Breaking Medicine News(10 mins):